Wertpapierdatensatz · archiviertes Quartal
VRNA
Verona Pharma plc · Healthcare · Biotechnology
15Erfasste Halter
+1Δ Inhaber
9.80MGehaltene Aktien
$926.97MGemeldeter Wert
+1Neue Positionen
−0Ausstiege
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +7.1% ·
Aktienfluss +10.0% ·
neue Nettopositionen +6.7%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q3 2025 | 17 | -1 | 15.38M | $1.64B | +3 | −4 |
| Q2 2025 | 15 | +1 | 9.80M | $926.97M | +1 | — |
| Q1 2025 | 12 | +1 | 8.25M | $524.09M | +1 | — |
| Q4 2024 | 11 | +3 | 8.58M | $398.41M | +3 | — |
| Q3 2024 | 8 | -1 | 5.38M | $154.86M | +1 | −2 |
| Q2 2024 | 9 | — | 3.45M | $49.92M | — | — |
Wer es hält · Q2 2025
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 1.79M | -4.1% | $169.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 2 | Wellington Management ✦ | 1.63M | -23.5% | $154.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 3 | Wellington Management ✦ | 1.63M | -23.5% | $154.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 4 | Wellington Management ✦ | 1.63M | -23.5% | $154.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.63M | -23.5% | $154.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.63M | -23.5% | $154.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.63M | -23.5% | $154.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.63M | -23.5% | $154.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 1.42M | +130.5% | $133.85M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.40M | +306.3% | $132.09M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 1.40M | +306.3% | $132.09M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 12 | Duquesne Family Office ✦ | 1.00M | 0.0% | $94.78M | 2.4% | Held | 4 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 816.72K | -49.9% | $77.24M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 14 | Millennium Management ✦ | 377.17K | +16.6% | $35.67M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 350.54K | +342.5% | $33.15M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 16 | BlackRock ✦ (passiv) | 343.70K | — | $32.51M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passiv) | 343.70K | — | $32.51M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passiv) | 343.70K | — | $32.51M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passiv) | 343.70K | — | $32.51M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Fidelity (FMR) ✦ | 312.39K | — | $29.55M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Fidelity (FMR) ✦ | 312.39K | — | $29.55M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 147.40K | +48.9% | $13.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Point72 Asset Management ✦ | 118.58K | +25.7% | $11.22M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passiv) | 68.43K | +18.6% | $6.47M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Marshall Wace ✦ | 26.35K | +113.7% | $2.49M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | State Street Global Advisors ✦ (passiv) | 6.32K | Neu | $597,746 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| State Street Global Advisors | $597,746 | 0.0% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q2 2025 ·
Methodik ·
Über die API abrufen